1)Hardcastle JD, Chamberlain JO, Robinson MH, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 348:1472-1477, 1996
2)Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med 328:1365-1371, 1993
3)Shaukat A, Mongin SJ, Geisser MS, et al. Long-term mortality after screening for colorectal cancer. N Engl J Med 369:1106-1114, 2013
4)Atkin WS, Edwards R, Kralj-Hans I, et al. Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer:a multicentre randomised controlled trial. Lancet 375:1624-1633, 2010
5)Schoen RE, Pinsky PF, Weissfeld JL, et al. Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy. N Engl J Med 366:2345-2357, 2012
6)Zauber AG, Winawer SJ, O'Brien MJ, et al. Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N Engl J Med 366:687-696, 2012
7)Nishihara R, Wu K, Lochhead P, et al. Long-term colorectal- cancer incidence and mortality after lower endoscopy. N Engl J Med 369:1095-1105, 2013
8)Benson VS, Atkin WS, Green J, et al. Toward standardizing and reporting colorectal cancer screening indicators on an international level:The International Colorectal Cancer Screening Network. Int J Cancer 130:2961-2973, 2012
9)Saito H. Colorectal cancer screening using immunochemical faecal occult blood testing in Japan. J Med Screen 13(Suppl 1):S6-7, 2006
10)Lieberman DA, Rex DK, Winawer SJ, et al. Guidelines for colonoscopy surveillance after screening and polypectomy:a consensus update by the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology 143:844-857, 2012
11)Lieberman DA, Holub JL, Morris CD, et al. Low rate of large polyps(>9mm)within 10 years after an adequate baseline colonoscopy with no polyps. Gastroenterology 147:343-350, 2014
12)Singh H, Turner D, Xue L, et al. Risk of developing colorectal cancer following a negative colonoscopy examination:evidence for a 10-year interval between colonoscopies. JAMA 295:2366-2373, 2006
13)Lakoff J, Paszat LF, Saskin R, et al. Risk of developing proximal versus distal colorectal cancer after a negative colonoscopy:a population-based study. Clin Gastroenterol Hepatol 6:1117-1121, 2008
14)le Clercq CM, Bouwens MW, Rondagh EJ, et al. Postcolonoscopy colorectal cancers are preventable:a population-based study. Gut 63:957-963, 2014
15)Singh S, Singh PP, Murad MH, et al. Prevalence, risk factors, and outcomes of interval colorectal cancers:a systematic review and meta-analysis. Am J Gastroenterol 109:1375-1389, 2014
16)工藤進英.早期大腸癌─平坦・陥凹型へのアプローチ.医学書院,1993
17)Quintero E, Castells A, Bujanda L, et al. Colonoscopy versus fecal immunochemical testing in colorectal-cancer screening. N Engl J Med 366:697-706, 2012
18)工藤進英,児玉健太.大腸がん検診における内視鏡の役割─Akita studyを中心に.日消誌 111:495-499, 2014
19)Winawer SJ, Zauber AG, O'Brien MJ, et al. Randomized comparison of surveillance intervals after colonoscopic removal of newly diagnosed adenomatous polyps. The National Polyp Study Workgroup. N Engl J Med 328:901-906, 1993
20)Winawer SJ, Zauber AG, Ho MN, et al. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med 329:1977-1981, 1993
21)Hassan C, Quintero E, Dumonceau JM, et al. Post-polypectomy colonoscopy surveillance:European Society of Gastrointestinal Endoscopy(ESGE)Guideline. Endoscopy 45:842-851, 2013
22)Sano Y, Fujii T, Matsuda T, et al. Study design and patient recruitment for the Japan Polyp Study. Open Access J Clin Trials 6:37-44, 2014
23)Matsuda T, Fujii T, Sano Y, et al. Five-year incidence of advanced neoplasia after initial colonoscopy in Japan:a multicenter retrospective cohort study. Jpn J Clin Oncol 39:435-442, 2009
24)Matsuda T, Fujii T, Sano Y, et al. Randomized comparison of surveillance intervals after colonoscopic removal of adenomatous polyps:Results from the Japan Polyp Study(DDW abstract). Gastroenterology 146:S161-162, 2014